Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.80 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.80 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.80 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.80 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.80 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.80 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.80 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9059706 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| Dihydrocapsaicin SCHEMBL29819467 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL117622 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29425544 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| Dihydrocapsaicin SCHEMBL119080 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL5348698 | 0.91 | CYP1A2 (0.90) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| Dihydrocapsaicin SCHEMBL28311536 | 0.91 | CYP1A2 (0.82) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL17778309 | 0.90 | CYP1A2 (0.82) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL17778308 | 0.90 | CYP1A2 (0.82) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL1703135 | 0.90 | CYP1A2 (0.81) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021058410-A1 | METHOD FOR CONTROLLED ELICITATION OF PEPPER PLANTS UNDER CULTIVATION TO INCREASE THEIR SYNTHESIS OF SECONDARY METABOLITES OF INDUSTRIAL INTEREST | ID4FEED (FR) | 2021-04-01 | — | — | WO | claimed |
| CN-111643492-A | Use of N-vanillylamide derivatives against lassa virus infection and diseases caused thereby | 中国医学科学院药物研究所 | 2020-09-11 | — | — | CN | claimed |
| US-20190218156-A1 | AGONIST/ANTAGONIST COMPOSITIONS AND METHODS OF USE | THE UNITED SATTES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH & HUMAN SERVICES (US) | 2019-07-18 | — | — | US | claimed |
| US-20160251276-A1 | AGONIST/ANTAGONIST COMPOSITIONS AND METHODS OF USE | THE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES (US) | 2016-09-01 | — | — | US | claimed |
| US-9277748-B2 | Agonist/antagonist compositions and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2016-03-08 | — | — | US | claimed |
| US-20130203736-A1 | AGONIST/ANTAGONIST COMPOSITIONS AND METHODS OF USE | USDHHS Office of Technology Transfer (US) | 2013-08-08 | — | — | US | claimed |
| US-7934888-B2 | Marine anti-foulant system and methods for using same | VIV SUPPRESSION, INC. (US) | 2011-05-03 | — | — | US | claimed |
| US-20090185867-A1 | MARINE ANTI-FOULANT SYSTEM AND METHODS FOR USING SAME | ASSET INTEGRITY MANAGEMENT SOLUTIONS, L.L.C., D/B/A AIMS INTERNATIONAL | 2009-07-23 | — | — | US | claimed |
| US-7270802-B2 | Non-lethal temporary incapacitation formulation and novel solvent system | ZARC INTERNATIONAL, INC. (US) | 2007-09-18 | — | — | US | claimed |
| WO-2004062641-A1 | NON-LETHAL TEMPORARY INCAPACITATION FORMULATION AND NOVEL SOLVENT SYSTEM | ZARC INTERNATIONAL, INC. (US) | 2004-07-29 | — | — | WO | claimed |
| US-20030129138-A1 | Non-lethal temporary incapacitation formulation and novel solvent system | ZARC INTERNATIONAL, INC. | 2003-07-10 | — | — | US | claimed |
| EP-4680210-A1 | MEDICAL PATCH COMPRISING SKIN IRRITATING ACTIVE AGENT | LTS Lohmann Therapie-Systeme AG (DE) | 2026-01-21 | — | — | EP | disclosed |
| CN-119909053-A | Application of dihydrocapsaicin in preventing and treating allergic rhinitis | 哈尔滨医科大学 | 2025-05-02 | — | — | CN | disclosed |
| US-12252647-B1 | Mehods of using plant edible demulsifier additives comprising capsaicinoid in subterranean formation treatment fluids, and systems related thereto | SAUDI ARABIAN OIL COMPANY (SA) | 2025-03-18 | — | — | US | disclosed |
| US-20030129138-A1 | Non-lethal temporary incapacitation formulation and novel solvent system | ZARC INTERNATIONAL, INC. | 2003-07-10 | — | — | US | disclosed |
| US-6063381-A | THERAPY FOR DEEP TISSUE OR FUNGICIDE | STAGGS JEFF J (US) | 2000-05-16 | — | — | US | disclosed |
| WO-1993023061-A1 | THERAPEUTIC USES OF PUNGENT BOTANICALS AND THEIR RELATED COMPOUNDS | STAGGS JEFF J (US) | 1993-11-25 | — | — | WO | disclosed |